Adam Kessel, MD

Mayo Clinic Rochester
Rochester, MN

Disclosures:

Presentations

Sep 29

2616 - Cost-Effectiveness of Vorasidenib for Patients with Isocitrate Dehydrogenase (IDH) Mutated Low-Grade Glioma (LGG)
Hall F
08:00am - 09:00am PT
Sep 29

2953 - Outcomes of Proton Therapy for Oligo-Adjacent Breast Cancer: A Multi-Institutional Evaluation
Hall F
03:00pm - 04:00pm PT
Sep 30

3460 - Stereotactic Body Radiation Therapy (SBRT) to Sites of Oligoprogression during Lutetium-177-PSMA-617 (Lu-PSMA) Treatment for Metastatic Castrate Resistant Prostate Cancer
Hall F
02:30pm - 03:45pm PT